Key result
Male and female patients with symptomatic heart failure had comparable rates of 24-month all-cause mortality after multivariate adjustment (HR 1.011), regardless of left ventricular ejection fraction status.
Why the study?
A lack of consensus remained regarding sex-related differences in prognosis within the new LVEF classification standard for heart failure.
Does sex affect 2-year prognosis in patients with heart failure grouped by LVEF status?
Cohort (n=2,284)
Yes
Does sex affect 2-year prognosis in patients with heart failure grouped by LVEF status?
Hazard Ratio: 1.011 (95% CI 0.831–1.398)
Absolute Event Rate: 21.8% vs 28.3%
p-value: p=0.574
Despite significant sex differences in baseline clinical characteristics among patients with HFrEF, HFmrEF, and HFpEF, men and women have comparable 2-year outcomes following hospitalization for heart failure.
Supports equivalent 2-year outcomes by sex across HF phenotypes; extends observational data but leaves open prospective confirmation.
After the new left ventricular ejection fraction (LVEF) classification criteria emerged, many studies have focused on the differences between heart failure (HF) with reduced EF (HFrEF), HF with midrange EF (HFmrEF), and HF with preserved EF (HFpEF). However, the lack of consensus on sex-related differences in prognosis within the new standard remains. We aimed to explore sex differences in the clinical characteristics and prognoses of Chinese inpatients with HF defined according to the new standard.From March 2014 to February 2016, 2284 patients with symptomatic HF were consecutively recruited to this prospective research. Case data and 2-year follow-up observations were used to identify sex differences in clinical characteristics and prognoses.When comparing men and women with HFrEF, HFmrEF, and HFpEF, women were older, were more likely to be hospitalized for the first diagnosis of HF, and had lower mean LVEF. Women had a higher tendency of all-cause mortality than did men at 3, 12, and 24 months following HF. After multivariate adjustment, the hazard ratios (HRs) for 24-month all-cause mortality for HFrEF, HFmrEF, and HFpEF were 1.113 (0.728, 1.704), P = 0.620; 1.063 (0.730, 1.548), P = 0.750; and 0.619 (0.240, 1.593), P = 0.320, for men versus women, respectively.There were some sex differences in the clinical characteristics of patients with symptomatic HF in HFrEF, HFmrEF, and HFpEF, but women and men had comparable outcomes over the 2-year period following hospitalization.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) conducted a cohort in Symptomatic heart failure (n=2,284). Male sex vs. Female sex was evaluated on 24-month all-cause mortality (HR 1.011, 95% CI 0.831-1.398, p=0.574). Male and female patients with symptomatic heart failure had comparable rates of 24-month all-cause mortality after multivariate adjustment (HR 1.011), regardless of left ventricular ejection fraction status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: